The limit of detection in scintigraphic imaging with I-131 in patients with differentiated thyroid carcinoma

By Hänscheid H   Lassmann M   Buck A K   Reiners C   Verburg F A  

Physics in Medicine and Biology, Vol. 59, Iss. 10, 2014-05 ,pp. : 2353-2368

IOP Publishing

Access to resources Recommend Favorite

Therapeutic administration of 131I for differentiated thyroid cancer, radiation dose to ovaries and outcome of

By Garsi J. P.   Schlumberger M.   Rubino C.   Ricard M.   Labbé M.   Ceccarelli C.   Schvartz C.   Henri-Amar H.   Bardet S.   De Vathaire F.  

Radioprotection, Vol. 43, Iss. 5, 2008-09 ,pp. : 039-039

Edp Sciences

Access to resources Recommend Favorite

The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative 131I dose over 37 GBq

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 1, 2015-07 ,pp. : 117-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical applications of SPECT/CT after first I‐131 ablation in patients with differentiated thyroid cancer

By  

CLINICAL ENDOCRINOLOGY, Vol. 81, Iss. 3, 2014-09 ,pp. : 445-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

THE HEART IN HYPERTHYROIDISM:† EFFECT OF ANTITHYROID DRUGS AND I131

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 5, Iss. 2, 1957-02 ,pp. : 109-116

John Wiley & Sons Inc

Access to resources Recommend Favorite